Login / Signup

RNA disruption indicates CHOP therapy efficacy in canine lymphoma.

Amadeo M ParissentiLaura B PritzkerBaoqing GuoRashmi NarendrulaShirly Xiaohui WangLin Laura LinJingchun PeiKarolina SkowronskiDorothee BienzleJ Paul WoodsKenneth P H PritzkerBrenda L Coomber
Published in: BMC veterinary research (2019)
Predicting the risk of early relapse during chemotherapy could benefit veterinary patients by reducing ineffective treatment and could allow veterinary oncologists to switch earlier to a more effective drug regimen.
Keyphrases
  • end stage renal disease
  • diffuse large b cell lymphoma
  • chronic kidney disease
  • ejection fraction
  • peritoneal dialysis
  • prognostic factors
  • stem cells
  • bone marrow
  • drug induced
  • adverse drug